GHK (without copper)

GHK is a tripeptide (Gly-His-Lys) naturally present in human plasma at approximately 200 ng/mL in young adults, declining to approximately 80 ng/mL by age 60. Its biological activity is mediated primarily through broad gene expression modulation rather than a single receptor interaction. Connectivity Map analysis revealed that GHK at 1 micromolar concentration modulates 4,000+ genes, including upregulation of collagen synthesis genes, DNA repair genes (GADD45A, XPA), antioxidant genes (TGM1, NQO1), and ubiquitin/proteasome components while downregulating inflammatory genes (IL-6, NF-kB pathway). GHK can chelate copper to form GHK-Cu, but the free peptide independently activates wound healing pathways, stimulates decorin production (a TGF-beta regulator), and promotes stem cell recruitment. The exact upstream mechanism by which GHK triggers these gene expression changes remains incompletely characterized.

Pickart et al. (2015) demonstrated that GHK modulates over 4,000 genes using Connectivity Map analysis, with gene expression changes favoring tissue remodeling and anti-inflammatory pathways. Pickart and Margolina (2018) compared free GHK and GHK-Cu effects in wound healing and skin regeneration, finding that the free peptide retains substantial activity. The gene expression data suggest potential applications in wound healing, anti-aging, and tissue regeneration, but functional validation through clinical trials is limited. Most published data are from in vitro and gene expression studies rather than controlled human outcomes studies.

GHK (free peptide) has no regulatory approval as a therapeutic agent. It is available as a cosmeceutical ingredient (INCI: Tripeptide-1) in topical formulations without FDA drug approval. Injectable and oral forms are available through grey-market vendors and compounding pharmacies. No IND or clinical trial registrations for the free peptide as a drug exist.

No established monitoring guidelines. For research purposes, wound healing assessments, skin quality measures, and inflammatory markers (CRP, IL-6) could be tracked. Copper and zinc levels may be relevant if using GHK in combination with mineral supplements.

These are general considerations for clinical awareness and do not constitute prescriptive monitoring recommendations for any individual patient.

Topical formulations: follow manufacturer storage instructions (typically room temperature). Injectable preparations (grey-market): supplied as lyophilized powder, store at 2 to 8 degrees C or minus 20 degrees C. Reconstitute with bacteriostatic water. GHK has good aqueous stability at physiological pH. In the presence of copper ions, GHK will spontaneously form the GHK-Cu complex.

1. 1

   review

   GHK Peptide: Broad Gene Modulatory Effects and Therapeutic Potential

   Pickart L, Vasquez-Soltero JM, Margolina A. (2015). BioMed Research International

   Key findings: GHK tripeptide (without copper) modulates expression of over 4,000 human genes at 1 micromolar concentration. Gene expression changes favor tissue remodeling, anti-inflammatory signaling, and antioxidant defense independent of copper complexation.

   Limitations: Gene expression data from Connectivity Map analysis. Functional validation limited. Differences between GHK and GHK-Cu effects not fully delineated.

   View source
2. 2

   review

   GHK and Wound Healing: Free Peptide vs. Copper Complex

   Pickart L, Margolina A. (2018). Journal of Cosmetic Dermatology

   Key findings: Comparison of free GHK and GHK-Cu in wound healing and skin regeneration. Free GHK retains significant biological activity through gene expression modulation, while copper complexation adds additional metalloproteinase and collagen remodeling effects.

   Limitations: Largely theoretical comparison. Limited head-to-head clinical data between the two forms. By the primary research group.